RBC Capital Sticks to Their Buy Rating for Thermo Fisher (TMO)
RBC Trims Price Target on Thermo Fisher Scientific to $711 From $718, Keeps Outperform Rating
Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675
CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $655
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $645 From $680
Morgan Stanley Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $670
Morgan Stanley Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $670
Thermo Fisher Is Maintained at Outperform by Evercore ISI Group
Thermo Fisher Price Target Cut to $620.00/Share From $630.00 by Evercore ISI Group
Wells Fargo Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $660
RBC Capital Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $718
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $655
Stifel Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Cuts Target Price to $665
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $610 to $718
Thermo Fisher Is Maintained at Equal-Weight by Barclays
Barclays Adjusts Price Target on Thermo Fisher Scientific to $610 From $620
Thermo Fisher Scientific Analyst Ratings
Bernstein Raises Thermo Fisher Scientific Price Target to $625 From $565, Maintains Market Perform Rating
Barclays Maintains Thermo Fisher Scientific(TMO.US) With Hold Rating, Maintains Target Price $620